Navigation Links
FDA's Chief of Staff, Susan Winckler and Peter Thonis, Chief Communications
Date:5/29/2008

Officer - Verizon Keynote at Leading Pharmaceutical Communication Event Where Executives Gather to Discuss Pressing Issues - The 4th Annual PR & Communications Summit for Pharmaceutical, Biotech and Medical Technology

Companies

NEW YORK, May 29 /PRNewswire/ -- ExL Pharma (http://www.exlpharma.com) is pleased to announce the participation of two keynote speakers from the U.S. Food and Drug Administration and Verizon during the 4th Annual Public Relations and Communications Summit: The Leading Event for Pharmaceutical, Biotech and Medical Technology Corporate and Brand Communicators taking place on July 14-15, 2008 at the Heldrich Conference Center in New Brunswick, N.J. (http://www.exlpharma.com/eventDetail.php?id=112) Susan Winckler, Chief of Staff at the FDA will share an update on improving communication issues with the FDA. This presentation is much anticipated as a result of ongoing press on the relationship between the agency and industry. Also confirmed to speak is Peter Thonis, Chief Communications Officer with Verizon. Mr. Thonis is going to lend his insight to the pharmaceutical executives in attendance on communicating with key stakeholders and keeping customers, an area that Verizon has had much success.

The 4th Annual Public Relations and Communications Summit (http://www.exlpharma.com/eventDetail.php?id=112) event brings together communication executives, press and agencies to discuss best practices and challenges relating to corporate, brand and internal communication strategies. Now in its 4th year, this premier event has grown to become the industry standard for senior executives seeking educational and networking opportunities in this field.

Additional program highlights include the number of industry case studies around key issues and challenges that our industry is currently facing. Topics that will be discussed include: new media tools, communicating more effectively with press, internal communications, handling a crisis, the ongoing reputation challenge, DTC advertising, key policy and legislative issues, ROI measurement, corporate social responsibility, agency/client relations, advocacy relations, marketing & PR collaboration, global PR, and much more.

Speakers include senior representatives from many of the leading pharmaceutical, biotech and medical technology companies such as: Abbott, BD, Centocor, Cephalon, Gilead, Genentech, Merck, Novartis, Pfizer, sanofi-aventis, Schering-Plough, Teva, Wyeth Pharmaceuticals and more.

This premier event is co-sponsored by DS Simon, Fleishman Hillard, Manning Salvage & Lee, MCS Public Relations, MultiVu, Ketchum, Healthstar PR, Medialink, Cision, Vocus, NAPS, & Cohn & Wolfe.

By attending this event, you will have the rare opportunity to networking with highly regarded communication executives from this industry, leading agency executives and key press/media such as the Wall Street Journal.

To maximize your company's exposure and take advantage of senior-level networking opportunities through sponsorship and exhibiting, please contact: Bryon Main, at bmain@exlpharma.com or by phone at 212-400-6246

To view the full program agenda and full roster of our expert speaking faculty and to REGISTER*
Log onto: http://www.exlpharma.com

* When registering, provide Registration and Priority Code: P218PR1

EARLY REGISTRATION RATES EXPIRE TOMORROW -MAY 30TH- REGISTER NOW AND SAVE

About ExL

ExL Pharma, a division of ExL Events, Inc., is an international leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.


'/>"/>
SOURCE ExL Pharma
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
2. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
3. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
4. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
5. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. China Technology Announces New Chief Financial Officer
8. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
9. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
10. GeneNews Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book
11. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... Total Orthopedics and Sports Medicine ... Solofuse-P™. The operation took place on Wednesday, January 11, 2017 at Long Island ... anterior cervical discectomy and fusion on a 42 year old female who was ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... again at the CHI SCOPE Summit for Clinical Ops Executives (Hyatt Regency Miami, ... panel discussions to examine vital clinical research issues such as trial performance metrics, ...
(Date:1/18/2017)... 18, 2017  HUYA Bioscience International, (HUYA), the leader ... pharmaceutical innovations, announced today a strategic collaboration ... Investment Company (referred to as CAS Innovation). The collaboration ... by leading scientists at CAS to meet the medical ... is the first company to have recognized ...
(Date:1/17/2017)... West Point, IA (PRWEB) , ... January 17, ... ... approval from China for Balance™ GT soybeans. The new Balance™ GT Soybean Performance ... tolerance to glyphosate and isoxaflutole, the active ingredient in the new Balance® Bean ...
Breaking Biology Technology:
(Date:12/20/2016)... 20, 2016 The rising popularity of ... leasing is stoking significant interest in keyless access ... Bluetooth low energy (BLE), biometrics and near-field communication ... wave of wireless technologies in the automotive industry. ... advanced access systems opens the market to specialist ...
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL anunció ... acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar a ... con múltiples sitios previstos a lo largo de Europa y Norteamérica. ... MSC-1 es el ... de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ciertos ...
(Date:12/16/2016)... 2016 Research and Markets has announced the ... Forecast to 2021" report to their offering. ... The biometric vehicle access system ... CAGR of 14.06% from 2016 to 2021. The market is estimated ... reach 854.8 Million by 2021. The growth of the biometric vehicle ...
Breaking Biology News(10 mins):